This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hiroshima Institute of Life Sciences. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Michishige Harada: Innovator in Hepatitis B Research
Introduction
Michishige Harada is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of medical research, particularly in the fight against viral infections. His work focuses on developing innovative solutions to combat hepatitis B virus (HBV) infections.
Latest Patents
Harada holds a patent for a "Human NTCP-Binding Antibody Capable of Inhibiting Infection of Hepatitis B Virus (HBV) to Human Hepatocytes." This groundbreaking invention aims to provide a new therapeutic approach to prevent HBV from infecting liver cells, which is crucial for managing hepatitis B infections.
Career Highlights
Harada is affiliated with the Hiroshima Institute of Life Sciences, where he conducts his research. His dedication to advancing medical science has led to the development of effective strategies to combat viral infections. His innovative work has garnered attention in the scientific community.
Collaborations
Harada has collaborated with notable colleagues, including Hiroyuki Osada and Kunitada Shimotohno. These partnerships have enhanced the research efforts in the field of hepatitis B and have contributed to the advancement of medical knowledge.
Conclusion
Michishige Harada's contributions to hepatitis B research exemplify the impact of innovation in medicine. His patent and collaborative efforts highlight the importance of scientific research in addressing global health challenges.